It was shown that patients with serologic responses, that is, a decreasing trend of serum CEA antigen, were more likely to present a statistically significant NLR fold- change (Thistlethwaite et al. 2017 ).
← all excerpts
Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end?
1
—
—